FDA Approval Activities for this Drug…

Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Capsules, Wyeth-Ayerst NDA 20-151/S16, S19, S20, S21, S22, S23, S25 & 20-699/S14, S18, S21, S23, S26, S27, S34 1/31/03 2/12/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, 37.5 mg, 75 mg, and 150 mg, Wyeth-Ayerst NDA 20-699/S-015, S016, 20-151/S017, S018 5/2/01 7/30/03 4/25/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, 37.5 mg, 75 mg, and 150 mg, Wyeth-Ayerst NDA 20-699/S-032 2/26/03 3/10/03 Effexor, Wyeth-Ayerst NDA 20-151/S17 & S18 5/2/01 4/23/03 Effexor XR, Wyeth-Ayerst NDA 20-151/S15 & S16 5/2/01 Effexor Indications: Prevention o relapse and recurrence of depression. Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth-Ayerst NDA 20-699/S-022 2/11/03 2/12/03 2/13/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth-Ayerst NDA 20-699/S-029 10/22/02 10/28/02 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules. Wyeth-Ayerst Research NDA 20-699/S-001 3/11/99 3/22/99 3/22/99 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules. Wyeth-Ayerst Research NDA 20-699/S-038 & S-043 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharmaceuticals Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules, Wyeth Pharmaceuticals Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules,Wyeth Pharmaceuticals Effexor, Wyeth Pharmaceuticals, Inc., NDA 020699S030 Effexor (venlafaxine hydrochloride) Immediate Release Tablets & Extended Release Capsules, Wyeth Pharmaceuticals | Effexor (venlafaxine hydrochloride) Immediate Release, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision

For the latest approval information and links for this API, please see the main page.